Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Coca-Cola Company (KO), PepsiCo, Inc. (PEP): Is There a Winner of the Soda Wars?

The soda war is a long-fought battle between two of America’s mega-cap companies. The Coca-Cola Company (NYSE:KO) and PepsiCo, Inc. (NYSE:PEP) fight on a daily basis to claim prominence among the world’s sparkling beverage consumers.  Investors might think that the two major soda stocks are impossible to differentiate.  They share so many characteristics that you might as well buy both or flip a coin.  But is it really that simple?  Or, on the other hand, are there actually stark differences between the two that you would be well-advised to dig into?

The Coca-Cola Company (NYSE:KO)The similarities are easy to detect

It’s absolutely true that the companies share similar business models and almost identical valuations.  Both Coke and Pepsi derive the bulk of their business from their namesake sparkling beverages.  In addition, the companies each pay dividends to shareholders and yield roughly 3% at current prices.  Furthermore, their stocks hold similar valuation profiles, with trailing twelve month price-to-earnings ratios of 19 times, forward P/E ratios of 16, and price-to-book ratios of 5.

The Coca-Cola Company (NYSE:KO) and PepsiCo, Inc. (NYSE:PEP) both sell sodas that taste fairly similar, even though each has its own die-hard fans.  A differentiating competitor is Dr Pepper Snapple Group Inc. (NYSE:DPS). Dr. Pepper Snapple is a much smaller rival, with a market capitalization of $9.5 billion, and offers a different group of soft drink brands including Dr. Pepper and 7UP.  Dr. Pepper Snapple also trades a little more cheaply than its two bigger siblings, selling at a trailing P/E of 14 with a dividend yield of 3.5% at recent prices.

Charting different paths

Underneath the similarities that lie on the surface, you may be surprised to hear that Coke and Pepsi have targeted different directions going forward.  You may not have noticed this because it’s a long, slow process to turn huge corporate ships like these.  But over the past few years, Pepsi has seriously branched out from its traditional soda business and effectively broadened its product portfolio.

Pepsi has a long list of brands that appeal to consumers. The company has taken measurable steps to diversify its product portfolio, with additions including Quaker Oats and Lays. Pepsi is much more than just a soda company. To that end, the company’s revenue is evenly split between food and beverages. In total, Pepsi has 22 brands that each brings in at least $1 billion in annual sales.

Coke has stood relatively still with their business operations.  For all intents and purposes, Coke is a one-trick pony. While it’s true that Coca-Cola holds the Dasani and Vitamin Water brands, soda beverages are still the company’s bread and butter. Coke’s core sparkling beverage segment, which includes such brands as Coca-Cola and Sprite, represented a full three-quarters of the company’s worldwide unit case volume in 2011.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.